Application of a resazurin-based high-throughput screening assay for the identification and progression of new treatments for human African trypanosomiasis.

Bowling, Tana; Mercer, Luke; Don, Robert; Jacobs, Robert; Nare, Bakela

Bowling, Tana; Mercer, Luke; Don, Robert; Jacobs, Robert; Nare, Bakela.

Afiliación

Bowling T; SCYNEXIS Inc., P.O. Box 12878, Research Triangle Park, NC 27709-2878, United States.
Mercer L; SCYNEXIS Inc., P.O. Box 12878, Research Triangle Park, NC 27709-2878, United States.
Don R; Drugs for Neglected Diseases initiative (DNDi), Geneva, Switzerland.
Jacobs R; SCYNEXIS Inc., P.O. Box 12878, Research Triangle Park, NC 27709-2878, United States.
Nare B; SCYNEXIS Inc., P.O. Box 12878, Research Triangle Park, NC 27709-2878, United States.

Int J Parasitol Drugs Drug Resist ; 2: 262-70, 2012 Dec.

Article en En | MEDLINE | ID: mdl-24533287

Palabras clave

High throughput screening; Hit-to-lead; Time to kill; Trypanosoma brucei brucei

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 2_ODS3 / 3_ND Problema de salud: 2_enfermedades_transmissibles / 3_neglected_diseases / 3_trypanosomiasis Tipo de estudio: Diagnostic_studies / Prognostic_studies / Screening_studies Idioma: En Revista: Int J Parasitol Drugs Drug Resist Año: 2012 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google